HIBERIX - Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)
Navigation: NDC > Supplier starting with: G > GLAXOSMITHKLINE BIOLOGICALS SA| Field | Value |
|---|---|
| NDC Code: | 58160-806 |
| Proprietary Name: | HIBERIX |
| Suffix: | |
| Non-Proprietary Name: | Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) |
| Dosage Form: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Method: | INTRAMUSCULAR |
| Original Marketing Date: | 24-08-2009 |
| Category Name: | BLA |
| Application Number: | BLA125347 |
| Labeler: | GLAXOSMITHKLINE BIOLOGICALS SA |
| Substance Name: | HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN |
| Active Numerator Strength: | 10 |
| Active Ingredient Unit: | ug/.5mL |
| Pharm Classes: | Inactivated Haemophilus Influenzae B Vaccine [EPC],Actively Acquired Immunity [PE],Haemophilus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] |
| DEA Schedule: |